Topiramate: Difference between revisions
From SEHK Wiki
| Line 47: | Line 47: | ||
*Increased by 1 to 3 mg/kg every 1 or 2 weeks until the effective dose is reached. | *Increased by 1 to 3 mg/kg every 1 or 2 weeks until the effective dose is reached. | ||
*About 5 to 9 mg/kg daily is usually required. | *About 5 to 9 mg/kg daily is usually required. | ||
|- | |||
!style="text-align: left"| Migraine prophylaxis | |||
| By mouth | |||
ADULT: | |||
*Initially 25 mg once daily at night for 1 week, then | |||
*Increased in steps of 25 mg every 1 week. | |||
*Usual dose 50 – 100 mg daily in 2 divided doses | |||
*Maximum 200 mg per day | |||
|} | |} | ||
Revision as of 22:42, 5 October 2020
Introduction
Topiramate is a medication used to treat epilepsy and prevent migraines. For epilepsy this includes treatment for generalized or focal seizures. It is also used as adjunctive treatment for seizures associated with Lennox-Gastaut syndrome.
| Generic Name 藥名 | HA Code 藥物代碼 | Classification藥物分類 |
|---|---|---|
| Topiramate Tablet 25 mg | TOPI01 | P1S1S3 |
| Topiramate Tablet 50 mg | TOPI01 | P1S1S3 |
| Topiramate Tablet 100 mg | TOPI03 | P1S1S3 |
Mechanism of Action
Anticonvulsant medication. It inhibits the sodium channels, calcium channels, GABA-A receptors, and carbonic anhydrase isoenzymes, contributing to the antiseizure effects.
Dosage
| For both adjunctive and monotherapy of epilepsy | By mouth
ADULT:
|
|---|---|
For monotherapy, CHILD 6 – 17 years:
| |
As adjunctive therapy, CHILD form 2 years of age:
| |
| Migraine prophylaxis | By mouth
ADULT:
|
